BioSpace: Portage Adds Four Adenosine Candidates to Pipeline in Tarus Buyout Media CoverageBy Dedrian KershawJuly 7, 2022...
Fierce Biotech: Portage raids fellow biotech Tarus for adenosine receptor treasures Media CoverageBy Dedrian KershawJuly 7, 2022...
ENDPOINTS: Low-profile biotech led by Bristol Myers vets grabs a suite of adenosine receptor antagonists via tiny buyout Media CoverageBy Dedrian KershawJuly 7, 2022...